Archive: 2026/03 - Page 2
How to Talk About Stopping or Tapering a Medication Safely
Learn how to safely talk to your provider about stopping or tapering medication. Understand why gradual reduction matters, how schedules vary by drug, and what communication makes tapering successful.
FDA Listing for Biosimilars: How They Are Evaluated and Approved
The FDA doesn't rate biosimilars like generics. Instead, it uses a strict, science-based process to ensure they're highly similar to reference biologics with no clinically meaningful differences. Learn how approval works, why they're not cheaper than expected, and what makes them different from generics.
Medications and Work Safety Risks: What Workers Need to Know
Workers taking opioids or benzodiazepines face higher injury risks, while healthcare staff handling chemotherapy drugs risk long-term health effects. Learn how exposure happens, what protections exist, and what needs to change.
- 1
- 2